ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

COR Cortex Pharmaceuticals,

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type
Cortex Pharmaceuticals, AMEX:COR AMEX Ordinary Share
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00 -

Brookfield Office Acquires Assets - Analyst Blog

11/06/2012 6:26pm

Zacks


Brookfield Office Properties Inc. (BPO), a real estate investment trust (REIT), has recently announced the acquisition of two office towers named Metropolitan Park East & West, in the Seattle central business district. Brookfield shelled out $210 million to acquire the 700,000 square-foot Class A office campus, of which $126 million came from the earlier obtained financing facility and the balance from its own cash reserves.

The two Metropolitan Park towers are 20 and 18 stories, respectively, and have a parking space for 867 cars. The towers are combined 85% leased and enjoy an excellent location advantage adjacent to Interstate 5 and the South Lake Union submarket.

This acquisition is beneficial to Brookfield as the Metropolitan towers are located in the strong Seattle market, which is home to a large number of technology and science companies with a highly skilled work force.  The acquisition is also in line with Brookfield's policy of owning premium properties in top urban markets with tenant diversification in the technology and social media sector.

Based in New York, Brookfield owns, develops and manages premier office properties in the United States, Canada and Australia. It also provides ancillary real estate service businesses, such as tenant service and amenities.

The company invests in high growth and high-barrier-to-entry markets, with its main focus on the creation and sustainability of growing streams of cash flow.

Brookfield currently retains a Zacks #3 Rank, which translates into a short-term Hold rating. We also have a long-term Neutral recommendation on the stock. One of its competitors, Core Site Realty Corporation (COR) holds a Zacks #2 Rank which translates into a short-term Buy rating.


 
BROOKFLD OFFICE (BPO): Free Stock Analysis Report
 
CORESITE REALTY (COR): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

1 Year Cortex Pharm Chart

1 Year Cortex Pharm Chart

1 Month Cortex Pharm Chart

1 Month Cortex Pharm Chart